
New environmental regulations and increasing consumer demand for corporate sustainability drive European pharmaceutical companies to commit to green chemistry processes. Ellie Gabel, associate editor for Revolutionized discusses.
Scaling up ecologically sound principles is no longer an option but a strategic priority to reduce waste, energy, and harmful substances during medicine manufacturing.
Current state of green chemistry adoption in European pharma
Green chemistry adoption is growing exponentially, with over 60 known instances of pharmaceutical entities implementing it in…